Expression of matrix metalloproteinase-9 and bombesin/gastrin-releasing peptide in human prostate cancers and their lymph node metastases

Acta Oncologica

Volumn 41, Issue 3, 2002, Pages 289-296

  Ishimaru, H ^b   Kageyama, Y ^b   Hayashi, T ^b   Nemoto, T ^b   Eishi, Y ^b   Kihara, K ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; CELLS; ENDOCRINOLOGY; ENZYMES; NEUROLOGY;

METASTASES;

ONCOLOGY;

BOMBESIN; ENOLASE; GASTRIN RELEASING PEPTIDE; GELATINASE B;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MOLECULE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION;

AGED; BOMBESIN; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; PROSTATIC NEOPLASMS;

EID: 0036331450     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860260088845     Document Type: Article

References (18)

1. Androgen-independent growth is induced by neuropeptides in human prostate cancer
2. Neuroendocrine differentiation in prostatic carcinoma
3. Neuroendocrine differentiation in prostatic carcinoma: An update
4. Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers
5. Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines
6. Bombesin stimulates growth of human prostate cancer cells in vitro
7. 125I-(Tyr 4) bombesin by tumor cells
8. Calcitonin-like immunoreactive and bombesin-like immunoreactive endocrine-paracrine cells of the human prostate
9. Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells
10. The expression of neuropeptides in hyperplastic and malignant prostate tissue and its possible clinical implications
11. High levels of intracellular bombesin characterize human small cell lung carcinoma
12. Bombesin analogues inhibit growth of small cell lung cancer in vitro and in vivo
13. Antagonists of bombesin/gastrin-releasing peptides as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer
14. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer
15. Somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostatic cancer in nude mice
16. Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II
17. Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice